These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18955531)

  • 1. In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.
    LiPuma JJ; Rathinavelu S; Foster BK; Keoleian JC; Makidon PE; Kalikin LM; Baker JR
    Antimicrob Agents Chemother; 2009 Jan; 53(1):249-55. PubMed ID: 18955531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Caverly LJ; Spilker T; Kalikin LM; Stillwell T; Young C; Huang DB; LiPuma JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
    Van Acker H; Van Snick E; Nelis HJ; Coenye T
    J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Narayanaswamy VP; Duncan AP; LiPuma JJ; Wiesmann WP; Baker SM; Townsend SM
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A; Crocetta V; Verginelli F; Di Bonaventura G
    FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis].
    Akışoğlu Ö; Engin D; Sarıçam S; Müştak HK; Şener B; Hasçelik G
    Mikrobiyol Bul; 2019 Jan; 53(1):22-36. PubMed ID: 30683036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L
    PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D; Mercer D; Lovie E; Robertson J; O'Neil D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6200-6. PubMed ID: 27503654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.
    Cunha MV; Sousa SA; Leitão JH; Moreira LM; Videira PA; Sá-Correia I
    J Clin Microbiol; 2004 Jul; 42(7):3052-8. PubMed ID: 15243059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Tabibi S; San Gabriel P; Zhou J; Liu Z; Lai L; Whittier S
    J Clin Microbiol; 2001 Nov; 39(11):3942-5. PubMed ID: 11682511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients].
    Ferroni A; Sermet-Gaudelus I; Abachin E; Quesnes G; Lenoir G; Berche P; Gaillard JL
    Pathol Biol (Paris); 2003 Sep; 51(7):405-11. PubMed ID: 12948761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis.
    Kurlandsky LE; Fader RC
    Pediatr Pulmonol; 2000 Mar; 29(3):210-2. PubMed ID: 10686042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.